Aerska raises €17.0M Seed round
2 October 2025· Dublin, Ireland· health, biotech, ai, b2b, deep_hardware
The fresh capital will enable the firm to advance its RNA medicines for brain diseases, improve its brain shuttle technology for targeted delivery, and expand research operations.
Investors
Leadage1
Also participating
SpeedinvestEntrepreneur FirstNorrsken VCBacked VCAda VenturesLingottoBlueYard CapitalKerna VenturesPsyMed Ventures
About Aerska
Stage
Series A
Headquarters
Dublin, Ireland
Founded
2025
Team Size
21–50
Sectors
healthbiotechaib2bdeep_hardware